Age-Related Macular Degeneration: Nonneovascular Early AMD, Intermediate AMD, and Geographic Atrophy

Retina: Fourth Edition

Volumn 2-3, Issue , 2005, Pages 1041-1074

  Bressler, Susan B ^a   Bressler, Neil M ^a   Sarks, Shirley H ^b   Sarks, John P ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84917036192     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02598-0.50066-5     Document Type: Chapter

References (161)

1. Ferris FL Senile macular degeneration: review of epidemiologic features. Am J Epidemiol 1983, 118:132-151.
2. The Age-Related Eye Disease Study Research Group Potential public health impact of AREDS results: AREDS report no. 11. Arch Ophthalmol 2003, 121:1621-1624.
3. The Eye Diseases Prevalence Research Group Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004, 122:567-572.
4. Klein R, Klein BEK, Jensen SC, et al. The five-year incidence and progression of age-related maculopathy. Ophthalmology 1997, 104:7-21.
5. Evans J, Wormold R Is the incidence of registrable age-related macular degeneration increasing?. Br J Ophthalmol 1996, 80:9-14.
6. Gass JDM Drusen and disciform macular detachment and degeneration. Arch Ophthalmol 1973, 90:206-217.
7. Haab O Erkrankungen der Macula Lutea. Centralblat Augenheilkd 1885, 9:384-391. (Cited by Duke-Elder S. System of ophthalmology, vol. 9. London: Kimpton; 1966.).
8. Piguet B, Haimovici R, Bird AC Dominantly inherited drusen represent more than one disorder: a historical review. Eye 1995, 9:34-41.
9. Gass JDM Pathogenesis of disciform detachment of the neuroepithelium (parts I and III). Am J Ophthalmol 1967, 63:573-711.
10. Bird AC, Bressler NB, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 1995, 39:367-374.
11. Klein R, Klein BEK, Linton KLP Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1992, 99:933-943.
12. The Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001, 119:1417-1436.
13. Mitchell P, Smith W, Attebo K, et al. Prevalence of age-related maculopathy in Australia. Ophthalmology 1995, 102:1450-1460.
14. Wang Q, Chappell RJ, Klein R, et al. Patterns of age-related maculopathy in the macular area, the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1996, 37:2234-2242.
15. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam study. Ophthalmology 1995, 102:205-210.
16. Wang JJ, Mitchell P, Smith W, et al. Bilateral involvement by age-related maculopathy lesions in a population, the Blue Mountains Eye Study. Br J Ophthalmol 1998, 82:743-747.
17. Bressler NM, Bressler SB, West SK, et al. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 1989, 107:847-852.
18. Gregor Z, Bird AC, Chisholm IH Senile disciform macular degeneration in the second eye. Br J Ophthalmol 1977, 61:141-147.
19. Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991, 98:1128-1134.
20. Green WR, McDonnell PJ, Yeo JH Pathologic features of senile macular degeneration. Ophthalmology 1985, 92:615-627.
21. Green WR, Enger C Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman lecture. Ophthalmology 1993, 100:1519-1535.
22. Sarks SH Aging and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol 1976, 60:324-341.
23. Spraul CW, Grossniklaus HE Characteristics of drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration. Arch Ophthalmol 1997, 115:267-273.
24. van der Schaft TL, Mooy CM, de Bruijn WC, et al. Histologic features of the early stages of age-related macular degeneration. A statistical analysis. Ophthalmology 1992, 99:278-286.
25. Curcio CA, Medeiros NE, Millican CL The Alabama age-related macular degeneration grading system for donor eyes. Invest Ophthalmol Vis Sci 1998, 39:1085-1096.
26. Laatikainen L, Karinkari J Capillary-free area of the fovea with advancing age. Invest Ophthalmol Vis Sci 1977, 161:1154-1157.
27. Grunwald JE, Piltz J, Patel N, et al. Effect of aging on retinal macular microcirculation: a blue-field simulation study. Invest Ophthalmol Vis Sci 1994, 34:3609-3613.
28. Groh MJM, Michelson G, Langhans MJ, et al. Influence of age on retinal and optic nerve head blood circulation. Ophthalmology 1996, 103:529-534.
29. Ibrahim YWM, Bots ML, Mulder PGH, et al. Number of perifoveal vessels in aging, hypertension, and atherosclerosis: the Rotterdam Study. Invest Ophthalmol Vis Sci 1998, 39:1049-1053.
30. Gao H, Hollyfield JG Aging of the human retina: differential loss of neurons and retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1992, 33:1-17.
31. Rubin GS, West SK, Munoz B, et al. A comprehensive assessment of visual impairment in a population of older Americans, the SEE study. Invest Ophthalmol Vis Sci 1977, 38:557-568.
32. Sandberg MA, Gaudio AR Slow photostress recovery and disease severity in age-related macular degeneration. Retina 1995, 15:407-412.
33. Liem AT, Keunen JE, van Norren D Clinical applications of fundus reflection densitometry. Surv Ophthalmol 1996, 41:37-50.
34. Curcio CA, Millican CL, Allen KA, et al. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci 1993, 34:3278-3296.
35. Dorey CK, Wu G, Ebenstein D, et al. Cell loss in the aging retina: relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci 1989, 30:1691-1699.
36. Feeney-Burns L, Burns RP, Gao C Age-related macular changes in humans over 90 years old. Am J Ophthalmol 1990, 109:265-278.
37. Marshall J, Grindle J, Ansell PL, et al. Convolution in human rods: an ageing process. Br J Ophthalmol 1979, 63:181-187.
38. Curcio CA, Medeiros NE, Millican CL Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996, 37:1236-1249.
39. Young RW The Bowman Lecture, 1982. Biological renewal: applications to the eye. Trans Ophthalmol Soc UK 1982, 102:42-75.
40. Feeney-Burns L, Berman ER, Rothman H Lipofuscin of human retinalpigment epithelium. Am J Ophthalmol 1980, 90:783-791.
41. Young RW Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987, 31:291-306.
42. Rakoczy PE, Baines M, Kennedy C, et al. Correlation between autofluorescent debris accumulation and the presence of partially processed forms of cathepsin D in cultured retinal pigment epithelial cells challenged with rod outer segments. Exp Eye Res 1996, 63:159-167.
43. Feeney-Burns L, Hilderbrand ES, Eldridge S Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. Invest Ophthalmol Vis Sci 1984, 25:195-200.
44. Beatty S, Boulton M, Henson D, et al. Macular pigment and age-related macular degeneration. Br J Ophthalmol 1999, 83:867-877.
45. Kennedy CJ, Rakoczy PE, Constable IJ Lipofuscin of the retinal pigment epithelium: a review. Eye 1995, 9:763-771.
46. von Ruckmann A, Fitzke FW, Bird AC In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol 1997, 115:609-615.
47. Delori FC, Dorey CK, Staurenghi G, et al. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 1995, 36:718-729.
48. Panda-Jonas S, Jonas JB, Jakobczyk-Zmija M Retinal pigment epithelial cell count, distribution, and correlations in normal human eyes. Am J Ophthalmol 1996, 121:181-189.
49. Gass JDM Stereoscopic atlas of macular diseases: diagnosis and treatment 1997, Mosby, St Louis. 4th edn.
50. Ramrattan RS, van der Schaft TL, Mooy CM, et al. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci 1994, 35:2857-2864.
51. Karwatowski WSS, Jeffries TE, Duance VC, et al. Preparation of Bruch's membrane and analysis of the age-related changes in the structural collagens. Br J Ophthalmol 1995, 79:944-952.
52. Holz FG, Owens SL, Marks J, et al. Ultrastructural findings in autosomal dominant drusen. Arch Ophthalmol 1997, 115:788-792.
53. van der Schaft TL, de Bruijn WC, Mooy CM, et al. Is basal laminar deposit unique for age-related macular degeneration?. Arch Ophthalmol 1991, 109:420-425.
54. Marshall GE, Konstas AGP, Reid GG, et al. Type IV collagen and laminin in Bruch's membrane and basal linear deposit in the human macula. Br J Ophthalmol 1992, 76:607-614.
55. Feeney-Burns L, Ellersieck MR Age-related changes in the ultrastructure of Bruch's membrane. Am J Ophthalmol 1985, 100:686-697.
56. Burns RP, Feeney-Burns L Clinico-morphologic correlations of drusen of Bruch's membrane. Trans Am Ophthalmol Soc 1980, 78:206-225.
57. Ishibashi T, Sorgente N, Patterson R, et al. Aging changes in Bruch's membrane of monkeys: an electron microscopic study. Ophthalmologica 1986, 192:179-190.
58. Killingsworth MC Age-related components of Bruch's membrane in the human eye. Graefes Arch Clin Exp Ophthalmol 1987, 225:406-412.
59. Holz FG, Sheraidah G, Pauleikhoff D, et al. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol 1994, 112:402-406.
60. Klein R, Klein BEK, Jensen SC, et al. The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 1998, 116:506-513.
61. Sheraidah G, Steinmetz R, Maguire J, et al. Correlation between lipids extracted from Bruch's membrane and age. Ophthalmology 1993, 100:47-52.
62. Pauleikhoff D, Harper CA, Marshall J, et al. Aging changes in Bruch's membrane: a histochemical and morphologic study. Ophthalmology 1990, 97:171-178.
63. Spaide RF, Ho-Spaide WC, Browne R, et al. Characterization of peroxidized lipids in Bruch's membrane. Retina 1999, 19:141-147.
64. Holz FG, Bellmann C, Margaritidis M, et al. Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1999, 237:145-152.
65. Moore DJ, Hussain AA, Marshall J Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci 1995, 36:1290-1297.
66. Starita C, Hussain AA, Patmore A, et al. Localization of the site of major resistance to fluid transport in Bruch's membrane. Invest Ophthalmol Vis Sci 1997, 38:762-767.
67. Marshall J, Hussain AA, Starita C, et al. The retinal pigment epithelium: function and disease 1998, Oxford University Press, New York.
68. Grunwald JE, Hariprasad SM, Dupont J Effect of aging on foveolar choroidal circulation. Arch Ophthalmol 1998, 116:150-154.
69. Curcio CA, Millican CL Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol 1999, 117:329-339.
70. Zarbin MA Age-related macular degeneration: review of pathogenesis. Eur J Ophthalmol 1998, 8:199-206.
71. Löffler KU, Lee WR Basal linear deposit in the human macula. Graefes Arch Clin Exp Ophthalmol 1986, 224:493-501.
72. van der Schaft TL, Mooy CM, de Bruijn WC, et al. Immunohistochemical light and electron microscopy of basal laminar deposit. Graefes Arch Clin Exp Ophthalmol 1994, 232:40-46.
73. Hirata A, Feeney-Burns L Autoradiographic studies of aged primate macular retinal pigment epithelium. Invest Ophthalmol Vis Sci 1992, 33:2079-2090.
74. Löffler KU, Lee WR Terminology of sub-RPE deposits: do we all speak the same language?. Br J Ophthalmol 1998, 82:1104-1105.
75. Bressler NM, Silva JC, Bressler SB, et al. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina 1994, 14:130-142.
76. Green WR, Key SN Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc 1997, 75:180-254.
77. Sarks JP, Sarks SH, Killingsworth MC Evolution of soft drusen in age-related macular degeneration. Eye 1994, 8:269-283.
78. El Baba F, Green WR, Fleischmann J, et al. Clinicopathologic correlation of lipidization and detachment of the retinal pigment epithelium. Am J Ophthalmol 1986, 101:576-583.
79. Sarks JP, Sarks SH, Killingsworth M Evolution of geographic atrophy of the retinal pigment epithelium. Eye 1988, 2:552-577.
80. Greaves AH, Sarks JP, Sarks SH Adult vitelliform macular degeneration: a clinical spectrum. Aust NZ J Ophthalmol 1990, 18:171-178.
81. Penfold PL, Killingsworth MC, Sarks SH Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol 1985, 223:69-76.
82. Sarks JP, Sarks SH, Killingsworth MC Morphology of early choroidal neovascularisation in age-related macular degeneration. Eye 1997, 11:515-522.
83. Killingsworth MC, Sarks JP, Sarks SH Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 1990, 4:613-621.
84. Bressler NM, Bressler SB, Seddon JM, et al. Drusen characteristics in patients with exudative versus nonexudative age-related macular degeneration. Retina 1988, 8:108-114.
85. Chuang MD, Bird AC The pathogenesis of tears of the retinal pigment epithelium. Am J Ophthalmol 1988, 105:285-290.
86. Eye Disease Case-Control Study Group Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992, 110:1701-1708.
87. Macular Photocoagulation Study Group Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 1997, 115:741-747.
88. Barondes M, Pauleikhoff D, Chisholm IC, et al. Bilaterality of drusen. Br J Ophthalmol 1990, 74:180-182.
89. Arnold JJ, Quaranta M, Soubrane G, et al. Indocyanine green angiography of drusen. Am J Ophthalmol 1997, 124:344-356.
90. Gass JDM, Jallow S, Davis B Adult vitelliform macular detachment occurring in patients with basal laminar drusen. Am J Ophthalmol 1985, 99:445-459.
91. Dusek J, Streicher T, Schmidt K Hereditäre Drusen der Bruchschen Membran II Untersuchung von Semidtünnschnitten und elektronenmikroskopischen Ergebnissen. Klin Monatsbl Augenheilkd 1982, 181:79-83.
92. Streicher T, Schmidt K, Dusek J Hereditäre Drusen der Bruchschen Membran. I. Klinische und lichtmikroskopische Beobachtungen. Klin Monatsbl Augenheilkd 1982, 181:27-31.
93. Sarks SH, Arnold JJ, Killinsworth MC, et al. Early drusen formation in the normal and aging eye and their relationship to age-related maculopathy: a clinicopathological study. Br J Ophthalmol 1999, 83:358-368.
94. Hageman GS, Mullins RF Molecular composition of drusen as related to substructural phenotype. Mol Vis 1999, 5:28-37.
95. Coffey AJH, Brownstein S The prevalence of macular drusen in postmortem eyes. Am J Ophthalmol 1986, 102:164-171.
96. Bressler NM, Munoz B, Maguire MG, et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities, Chesapeake Bay Watermen study. Arch Ophthalmol 1995, 113:301-308.
97. Capon MRC, Marshall J, Krafft JI, et al. Sorsby's fundus dystrophy: a light and electron microscopic study. Ophthalmology 1989, 96:1769-1777.
98. Sarks SH Drusen patterns predisposing to geographic atrophy of the retinal pigment epithelium. Aust J Ophthalmol 1982, 10:91-97.
99. Leys A, Vanrenterghem Y, Van Damme B, et al. Fundus changes in membranoproliferative glomerulonephritis type II: a fluorescein angiographic study of 23 patients. Graefes Arch Clin Exp Ophthalmol 1991, 229:406-410.
100. Sarks SH Drusen and their relationship to senile macular degeneration. Aust J Ophthalmol 1980, 8:117-130.
101. Bird AC Pathogenesis of retinal pigment epithelial detachment in the elderly: the relevance of Bruch's membrane change, Doyne lecture. Eye 1991, 5:1-12.
102. Casswell AG, Kohen D, Bird AC Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 1985, 69:397-403.
103. Hartnett ME, Weiter JJ, Garsd A, et al. Classification of retinal pigment epithelial detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol 1992, 230:11-19.
104. Holz FG, Wolfensberger TJ, Piguet B, et al. Bilateral macular drusen in age-related macular degeneration: prognosis and risk factors. Ophthalmology 1994, 101:1522-1528.
105. Duvall J, Tso MOM Cellular mechanisms of resolution of drusen after laser photocoagulation: an experimental study. Arch Ophthalmol 1985, 103:694-703.
106. Ruskovic D, Ulbig MW, Mueller AJ, et al. Cellular response to hard drusen and lipid deposits in human Bruch's membrane following diode laser photocoagulation. Invest Ophthalmol Vis Sci 1998, 39(suppl.):369.
107. The Choroidal Neovascularization Prevention Trial Research Group Laser treatment in eyes with large drusen: short-term effects seen in a pilot randomized clinical trial. Ophthalmology 1998, 105:11-23.
108. The Complications of Age-Related Macular Degeneration Prevention Trial Study Group The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): rationale, design, methodology. Clin Trials 2004, 1:91-107.
109. Figueroa MS, Regueras A, Bertrand J, et al. Laser photocoagulation for macular soft drusen: updated results. Retina 1997, 17:378-384.
110. Ho AC, Maguire MG, Yoken J, et al. Laser-induced drusen reduction improves visual function at 1 year. Ophthalmology 1999, 106:1367-1374.
111. Klein R, Klein BEK, Jensen SC The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy, Beaver Dam Eye Study. Ophthalmology 1997, 104:1804-1812.
112. Little HL, Showman JM, Brown BW, et al. A pilot randomized controlled study on the effect of laser photocoagulation of confluent soft macular drusen. Ophthalmology 1997, 104:623-631.
113. Owen SL, Guymer R, Gross-Jendroska M, et al. Fluorescein angiographic abnormalities after prophylactic macular photocoagulation for high-risk age-related maculopathy. Am J Ophthalmol 1999, 127:681-687.
114. Olk RJ, Friberg TR, Stickney KL, et al. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study. Ophthalmology 1999, 106:2082-2090.
115. Arnold JJ, Sarks SH, Killingsworth MC, et al. Reticular pseudodrusen: a risk factor in age-related maculopathy. Retina 1995, 15:183-191.
116. Mimoun G, Soubrane G, Coscas G Macular drusen. J Fr Ophtalmol 1990, 13:511-530.
117. Dickinson AJ, Sparrow JM, Duke AM, et al. Prevalence of age-related maculopathy at two points in time in an elderly British population. Eye 1997, 11:301-314.
118. Maguire MG More pieces for the age-related macular degeneration puzzle. Ophthalmology 1997, 104:5-6.
119. Sarraf D, Gin T, Yu F, et al. Long-term drusen study. Retina 1999, 19:513-519.
120. The Age-Related Eye Disease Study Research Group. Report no. 16. Ocular risk factors for development of neovascular age-related macular degeneration in the fellow eyes of patients with unilateral neovascular AMD. AREDS Report No. 20. Arch Ophthalmol 2005; in press.
121. Pauleikhoff D, Zuels S, Sheraidah GS, et al. Correlation between biochemical composition and fluorescein binding of deposits in Bruch's membrane. Ophthalmology 1992, 99:1548-1553.
122. Mullins RF, Johnson LV, Anderson DH, et al. Characterization of drusen-associated glycoconjugates. Ophthalmology 1998, 104:288-298.
123. Hageman GS. Pathogenesis and treatment of age-related macular degeneration. Paper presented at the Twenty-eighth Anniversary Meeting, The Wilmer Ophthalmological Institute at Johns Hopkins, June 4-6, 1998.
124. Mullins RF, Hageman GS Human ocular drusen possess novel core domains with a distinct carbohydrate composition. J Histochem Cytochem 1999, 47:1533-1539.
125. Hageman GS, Mullins RF, Russell SR, et al. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J 1999, 13:477-484.
126. Penfold PL, Killingsworth MC, Sarks SH Senile macular degeneration: the involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1986, 27:364-371.
127. Spraul CW, Lang GE, Grossniklaus HE Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci 1996, 37:2724-2735.
128. Spraul CW, Lang GE, Grossniklaus HE, et al. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol 1999, 44(suppl. 1):10-32.
129. Hayreh SS In vivo choroidal circulation and its watershed zones. Eye 1990, 4:273-289.
130. McLeod DS, Lutty GA High-resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol Vis Sci 1994, 35:3799-3811.
131. Pauleikhoff D, Chen JC, Chisholm IH, et al. Choroidal perfusion abnormality with age-related Bruch's membrane change. Ophthalmology 1990, 109:211-217.
132. Staurenghi G, Bottoni F, Lonati C, et al. Drusen and choroidal filling defects: a cross-sectional survey. Ophthalmologica 1992, 205:178-186.
133. Pauleikhoff D, Spital M, Radermacher M, et al. Regression of the choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci 1997, 38(suppl.):967.
134. Henkind P, Gartner S The relationship between retinal pigment epithelium and the choriocapillaris. Trans Ophthalmol Soc UK 1983, 103:444-447.
135. Glaser BM Extracellular modulating factors and the control of intraocular neovascularization. Arch Ophthalmol 1988, 106:603-607.
136. Friedman E, Krupsky S, Lane AM, et al. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology 1995, 102:640-646.
137. Chen JC, Fitzke FW, Pauleikhoff D, et al. Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci 1992, 33:334-340.
138. Steinmetz RL, Haimovici R, Jubb C, et al. Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol 1993, 77:549-554.
139. Remulla JFC, Gaudio AR, Miller S, et al. Foveal electroretinograms and choroidal perfusion characteristics in fellow eyes of patients with unilateral neovascular age-related macular degeneration. Br J Ophthalmol 1995, 79:558-561.
140. Piguet B, Palmvang TB, Chisholm IH, et al. Evolution of age-related macular degeneration with choroidal perfusion abnormality. Am J Ophthalmol 1992, 113:657-663.
141. Sunness JS, Massof RW, Johnson MA, et al. Diminished foveal sensitivity may predict the development of advanced age-related macular degeneration. Ophthalmology 1989, 96:375-381.
142. Sunness JS, Johnson MA, Massof RW, et al. Retinal sensitivity over drusen and nondrusen areas: a study using fundus perimetry. Arch Ophthalmol 1988, 106:1081-1084.
143. Schatz H, McDonald HR Atrophic macular degeneration: rate of spread of geographic atrophy and visual loss. Ophthalmology 1989, 96:1541-1551.
144. Sunness JS, Rubin GS, Applegate CA, et al. Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity. Ophthalmology 1997, 104:1677-1691.
145. Maguire P, Vine AK Geographic atrophy of the retinal pigment epithelium. Am J Ophthalmol 1986, 102:621-625.
146. Sunness JS, Applegate CA, Haselwood D, et al. Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt's disease. Ophthalmology 1996, 103:1458-1466.
147. Weiter JJ, Delori F, Dorey CK Central sparing in annular macular degeneration. Am J Ophthalmol 1988, 106:286-292.
148. Snodderly DM Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 1995, 62(suppl.):1448-1461.
149. Hyman LG, Lilienfeld AM, Ferris FL, et al. Senile macular degeneration: a case-control study. Am J Epidemiol 1983, 118:213-227.
150. Harris MJ, Robins D, Dieter JM, et al. Eccentric visual acuity in patients with macular disease. Ophthalmology 1985, 92:1550-1553.
151. Sunness JS, Gonzalez-Baron J, Applegate CA, et al. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology 1999, 106:1768-1779.
152. Weiter JJ, Wing GL, Trempe CL, et al. Visual acuity related to retinal distance from the fovea in macular disease. Ann Ophthalmol 1984, 16:174-176.
153. Sunness JS, Gonzalez-Baron J, Bressler NM, et al. The development of choroidal neovascularization in eyes with geographic atrophy form of age-related macular degeneration. Ophthalmology 1999, 106:910-919.
154. Shuttleworth GN, Luhishi EA, Harrad RA Do patients with age-related maculopathy and cataract benefit from cataract surgery?. Br J Ophthalmol 1998, 82:611-616.
155. Lewis H, Straatsma BR, Foos RY, et al. The prevalence of macular drusen in postmortem eyes. Am J Ophthalmol 1986, 102:801-803.
156. Alpha-tocopherol Beta Carotene Study, NEJM The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994, 330:1029-1035.
157. Fine AM, Elman MJ, Ebert JE, et al. Earliest symptoms caused by neovascular membranes in the macula. Arch Ophthalmol 1986, 104:513-514.
158. Achard OA, Safran AB, Duret FC, Ragama E Role of the completion phenomenon in the evaluation of Amsler grid results. Am J Ophthalmol 1995, 120:322-329.
159. Schuchard RA Validity and interpretation of Amsler grid report. Arch Ophthalmol 1993, 111:776-780.
160. Goldstein M, Loewenstein A, Barak A, et al. Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration. Retina 2005, 25:296-303.
161. Preferential Hyperacuity Perimetry (PHP) Research Group. Preferential Hyperacuity Perimeter (PreView PHP™) for detecting choroidal neovascularization study. Ophthalmology 2005; in press.